tiprankstipranks
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA

Verrica Pharmaceuticals (VRCA) Income Statement

298 Followers

Verrica Pharmaceuticals Income Statement

Last quarter (Q3 2023), Verrica Pharmaceuticals's total revenue was $2.92M, a decrease of -64.94% from the same quarter last year. In Q3, Verrica Pharmaceuticals's net income was $-24.26M. See Verrica Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 3.20M$ 9.03M$ 12.00M$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 3.20M$ 9.03M$ 12.00M---
Operating Expense
$ 39.48M$ 30.33M$ 42.91M$ 40.18M$ 30.08M$ 21.88M
Operating Income
$ -48.56M$ -21.30M$ -30.91M$ -40.18M$ -30.08M$ -21.88M
Net Non Operating Interest Income Expense
$ 634.00K$ -1.70M$ -4.17M$ -2.51M$ 1.88M$ 1.23M
Other Income Expense
$ 112.00K$ 1.46M-$ -1.00K$ -4.00K$ -1.00K
Pretax Income
$ -47.50M$ -23.00M$ -35.08M$ -42.69M$ -28.21M$ -20.65M
Tax Provision
$ -4.64M$ -955.00K$ -205.00K---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -47.77M$ -23.00M$ -35.08M$ -42.69M$ -28.21M$ -20.65M
Basic EPS
$ -1.28$ -0.72$ -1.30$ -1.71$ -1.13$ -1.41
Diluted EPS
$ -0.97$ -0.72$ -1.30$ -1.71$ -1.13$ -1.41
Basic Average Shares
$ 169.18M$ 34.16M$ 27.04M$ 25.00M$ 24.90M$ 14.66M
Diluted Average Shares
$ 169.18M$ 34.16M$ 27.04M$ 25.00M$ 24.90M$ 14.66M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 39.48M$ 30.33M$ 42.91M$ 40.18M$ 30.08M$ 21.88M
Net Income From Continuing And Discontinued Operation
$ -48.31M$ -24.49M$ -35.08M$ -42.69M$ -28.21M$ -20.65M
Normalized Income
$ -19.17M$ -23.95M-$ -42.69M$ -28.21M$ -20.65M
Interest Expense
---$ 3.03M$ 0.00$ 0.00
EBIT
$ -46.69M$ -20.83M$ -30.91M$ -39.66M$ -28.21M$ -21.88M
EBITDA
$ -23.46M$ -20.00M$ -30.37M$ -39.43M$ -27.95M$ -21.86M
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis